| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 12/27/2001 | WO2001028979A3 Inhibitors of neuraminidases |
| 12/27/2001 | US20010056152 Chlorinated vinyl chloride resin composition |
| 12/27/2001 | US20010056117 Oxygen-containing heterocyclic compounds |
| 12/27/2001 | US20010056113 Methods for the inhibition of angiogenesis with 6-amino EM-12 |
| 12/27/2001 | US20010056109 Imidazole derivatives |
| 12/27/2001 | US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 12/27/2001 | US20010056094 3-(Cycloalkanoheteroarylidenyl)-2-Indolinone Protein Tyrosine Kinase Inhibitors |
| 12/27/2001 | US20010056088 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors |
| 12/27/2001 | US20010055960 Rf receiver having cascaded filters and an intermediate amplifier stage |
| 12/27/2001 | CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413418A1 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413274A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2412985A1 Hiv integrase inhibitors |
| 12/27/2001 | CA2411585A1 Novel non-psychotropic cannabinoids |
| 12/27/2001 | CA2411255A1 Novel compounds |
| 12/27/2001 | CA2410452A1 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 12/26/2001 | CN1328596A Liquid crystal compound |
| 12/26/2001 | CN1328549A Substituted benzo [de] isoquinoline-1,3-diones |
| 12/26/2001 | CN1328546A Pyrrolidines as inhibitors of neuraminidases |
| 12/26/2001 | CN1328466A Use of antifungal agents for treating scleroses |
| 12/26/2001 | CN1076727C Novel triazolones as apolipoprotein-B synthesis inhibitors |
| 12/25/2001 | US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation |
| 12/25/2001 | US6333346 Aminofuranoneureas or thioureas 4-amino-2(5h)-thiophenones as antitumor agents |
| 12/25/2001 | US6333344 Prolines as antimicrobial agents |
| 12/25/2001 | US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics |
| 12/25/2001 | US6333338 Anticoagulants, cardiovascular disorders |
| 12/25/2001 | US6333325 Method of treating cytokine mediated diseases or conditions |
| 12/25/2001 | US6333324 For therapy and prophylaxis of matrix metalloproteinases (mmp) or tumor necrosis factor .alpha. (tnf.alpha.), mediated diseases |
| 12/25/2001 | US6333320 Hexahydro-1,4-diazepine derivatives or salts thereof |
| 12/25/2001 | CA2052424C 2-(4-piperidinyl)-1h-pyrido¬4,3-b|indol-1-ones and related compounds, intermediates and a process for their preparation |
| 12/25/2001 | CA2032602C 4-carbonyl-substituted coumarin compound |
| 12/22/2001 | CA2312252A1 5,6,7-trinor-4, 8-inter-m-phenylene pgi2 derivative and medicine containing the same |
| 12/20/2001 | WO2001096334A2 Heteroarylalkanoic acids as integrin receptor antagonists |
| 12/20/2001 | WO2001096331A1 Lactam inhibitors of factor xa and method |
| 12/20/2001 | WO2001096330A2 Thrombin receptor antagonists |
| 12/20/2001 | WO2001096327A1 BIOISOSTERIC BENZAMIDE DERIVATIVES AND THEIR USE AS APoB-100 SECRETION INHIBITORS |
| 12/20/2001 | WO2001096313A1 Distamycin a analogs |
| 12/20/2001 | WO2001096311A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 12/20/2001 | WO2001096308A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 12/20/2001 | WO2001096307A2 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 12/20/2001 | WO2001096303A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096302A1 Piperidines for use as orexin receptor antagonists |
| 12/20/2001 | WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | WO2001096283A2 Hiv integrase inhibitors |
| 12/20/2001 | WO2001095911A1 Protease inhibitors |
| 12/20/2001 | WO2001095905A1 Inhibitor for enzyme having two divalent metal ions as active centers |
| 12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
| 12/20/2001 | WO2001044207A3 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 12/20/2001 | WO2001016108A3 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 12/20/2001 | WO2000072832A3 Novel use of 1-[4-(cyanoindol-3yl)butyl]-4-(carbamoyl-benzofuran-5yl)-piperazine and its physiologically acceptable salts |
| 12/20/2001 | WO1999019304A3 Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors |
| 12/20/2001 | US20010053853 Alkanoic acid derivative; integrin receptor antagonist |
| 12/20/2001 | DE10030094A1 New phenyl-substituted 5,6-dihydro-pyrone derivatives, useful as total or selective herbicides, insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents |
| 12/20/2001 | CA2412979A1 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 12/20/2001 | CA2412857A1 Hiv integrase inhibitors |
| 12/20/2001 | CA2412618A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | CA2412353A1 Protease inhibitors |
| 12/20/2001 | CA2412216A1 Lactam inhibitors of factor xa and method |
| 12/19/2001 | EP1164134A1 Benzimidazole compounds and their use as modulators of the GABA A receptor complex |
| 12/19/2001 | EP1164133A2 Enantiomerically pure Beta-D-(-)-dioxolane-nucleosides |
| 12/19/2001 | EP1163238A1 Chemokine recpetor binding heterocyclic compounds |
| 12/19/2001 | EP1163237A1 Amide derivatives |
| 12/19/2001 | EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents |
| 12/19/2001 | EP1163229A1 2,4-diamino-1,3,5-triazines, method for producing them and their use as herbicides and plant growth regulators |
| 12/19/2001 | EP1163227A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |
| 12/19/2001 | EP1163225A1 Compounds and methods for modulation of estrogen receptors |
| 12/19/2001 | EP0785794B1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 12/19/2001 | EP0639080B1 Non-azo naphthalimide dyes and use as alkylating agents |
| 12/19/2001 | CN1327444A Alpha 1 beta-adrenergic receptor antagonists |
| 12/19/2001 | CN1327443A Substituted anilides |
| 12/18/2001 | USRE37478 1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics |
| 12/18/2001 | US6331629 Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines; dopamine receptor subtype specific ligands |
| 12/18/2001 | US6331562 Compounds and methods for modulation of estrogen receptors |
| 12/18/2001 | US6331556 Benzofuran-4-carboxylic acid amide derivatives used as phosphodiesterase iv or tumor necrosis factor inhibitors |
| 12/18/2001 | US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders |
| 12/18/2001 | US6331545 Heterocycyclic piperidines as modulators of chemokine receptor activity |
| 12/18/2001 | US6331544 Treating positive and negative symptoms of schizophrenia and other psychoses |
| 12/18/2001 | US6331542 Protease inhibitors |
| 12/18/2001 | US6331541 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/18/2001 | US6331537 Treating neurological disorders in animals |
| 12/18/2001 | US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 12/18/2001 | CA2213815C Pyrrolidinyl hydroxamic acid compounds and their production process |
| 12/18/2001 | CA2204290C Benzimidazole derivatives, their production and use |
| 12/18/2001 | CA2183071C A process for preparing optically active mevalonolactone compounds |
| 12/18/2001 | CA2006309C Azolylmethylcyclopentane benzylidene fungicide |
| 12/13/2001 | WO2001094341A1 Quinazoline derivatives for the treatment of tumours |
| 12/13/2001 | WO2001094339A1 Substituted pyridine herbicides |
| 12/13/2001 | WO2001094319A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
| 12/13/2001 | WO2001093841A2 Barbituric acid analogs as therapeutic agents |
| 12/13/2001 | WO2001093682A1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives |
| 12/13/2001 | WO2001045637A3 Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides |
| 12/13/2001 | WO2001044200A3 Selective neurokinin antagonists |
| 12/13/2001 | WO2001032647A3 Benz`f!indoles for use in the treatment of 5ht receptor related disorders |
| 12/13/2001 | US20010051730 Glycoprotein antagonist, inhibitor of blood platelet aggregation and fibrinogen binding |
| 12/13/2001 | US20010051728 Bromide salt formation and bromination of 1-methylpiperidin-4-one, reaction with 1,3,5-trimethoxybenzene, catalytic hydrogenation to cis compound; chemical intermediate in synthesis of flavopiridol |
| 12/13/2001 | US20010051640 C7 carbamoyloxy substituted taxanes |
| 12/13/2001 | US20010051638 Ethanol solvate of (-)-cis-2- (2-chlorophenyl)-5, 7-dihydroxy-8 [4R-(3S-hydroxy-1-M ethyl) piperidinyl} -4H-1-benzopyran-4-one |
| 12/13/2001 | US20010051625 Combined effects of dopamine D4 receptor ligands and serotonin reuptake inhibitors; schizophrenia; antidepressant; anxiolytic agents; psychological disorders; panic, sleep and obsessive compulsive disorders; antiischemic agents |
| 12/13/2001 | US20010051348 Complexing |
| 12/13/2001 | DE10001037C1 Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen Processes and intermediates for the preparation of imidazopyridines |